In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase.

Chem Commun (Camb)

College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014 Shandong, P. R. China.

Published: July 2018

We have constructed versatile drug-loaded nanoprobes capable of responding to both MUC1 and telomerase and achieving intracellular drug release. Besides, the synthesized drug-loaded nanoprobes can realize the in situ imaging observation of the whole process of nanoprobes targeting the tumor cell membrane, the transmembrane entering the cytoplasm and the release of DOX into the cell nucleus.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8cc05052jDOI Listing

Publication Analysis

Top Keywords

drug-loaded nanoprobes
8
situ fluorescence
4
fluorescence monitoring
4
monitoring diagnosis
4
diagnosis treatment
4
treatment versatile
4
versatile nanoprobe
4
nanoprobe combining
4
combining tumor
4
tumor targeting
4

Similar Publications

Although mitochondria have been identified as a potential therapeutic target for the treatment of various diseases, inefficient drug targeting to mitochondria is a major limitation for related therapeutic applications. In the current approach, drug loaded nanoscale carriers are used for mitochondria targeting via endocytic uptake. However, these approaches show poor therapeutic performance due to inefficient drug delivery to mitochondria.

View Article and Find Full Text PDF

Just-in-time evaluation of drug resistance in situ will greatly facilitate the achievement of precision cancer therapy. The rapid elevation of reactive oxygen species (ROS) is the key to chemotherapy. Hence, suppressed ROS production is an important marker for chemotherapy drug resistance.

View Article and Find Full Text PDF

Multi-antitumor therapy and synchronous imaging monitoring based on exosome.

Eur J Nucl Med Mol Imaging

July 2022

Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 430022, China.

Background: Tumor-derived exosomes (TEX) have shown great potential for drug delivery and tumor targeting. Here, we developed a novel multi-drug loaded exosomes nanoprobe for combined antitumor chemotherapy and photodynamic therapy, and monitoring the drug delivery capabilities with pre-targeting technique.

Methods: TEX of human colorectal cancer HCT116 was prepared, and Doxorubicin and the photodynamic therapy agent 5-aminolevulinic acid (ALA) were loaded and named as TEX@DOX@ALA.

View Article and Find Full Text PDF

Of all malignant brain tumors, glioma is the deadliest and most common, with a poor prognosis. Drug therapy is considered as a promising way to stop the progression of disease and even cure tumors. However, the presence of blood brain barrier (BBB) and blood tumor barrier (BTB) limits the delivery of these therapeutic genes.

View Article and Find Full Text PDF

pH-Responsive DNA nanoassembly for detection and combined therapy of tumor.

Biosens Bioelectron

January 2022

Key Laboratory of Phytochemical R&D of Hunan Province, And Key Laboratory of Chemical Biology & Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha, 410081, China.

Article Synopsis
  • Researchers have created a new cancer nanotherapy that has high safety, stability, and minimal toxicity, activated by the tumor environment for selective imaging and treatment.
  • The nanoassembly features specially designed DNA components and targeted molecules that allow it to identify and attack tumor cells effectively, releasing drugs in response to the acidic conditions typical of tumors.
  • The study demonstrates that this innovative nanoprobe can detect pH changes and combine multiple therapeutic strategies, highlighting its potential for improved cancer diagnosis and treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!